Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers.

Abstract

No abstract available.

Authors
  • Burnell M
  • Cline M
  • Dougall WC
  • Dubeau L
  • Fraser L
  • Gareth Evans D
  • Jacobs IJ
  • Menon U
  • Pan Y
  • Philpott S
  • Reisel D
  • Rosenthal AN
  • Widschwendter M
  • Wood CE
  • Yi PC
PubMed ID
Appears In